Former Shkreli-led drug developer pledges responsible pricing

(Reuters) - A biotechnology company, which was led by former drug executive Martin Shkreli, said on Monday it was making a commitment not to engage in aggressive pricing, and to develop a 'transparent and responsible' model for its products.

http://ift.tt/1oQws85

from Reuters: Health News
via animenewspro